Can You Take Azithromycin with Linezolid?
Yes, azithromycin can be safely co-administered with linezolid from a pharmacokinetic perspective, as there are no documented drug-drug interactions between these agents. However, this combination requires careful consideration of the specific clinical context, particularly regarding the risk of serotonin syndrome.
Drug Interaction Profile
The FDA labeling for linezolid explicitly addresses antibiotic combinations and does not list azithromycin as having any pharmacokinetic interactions 1. The key interaction data shows:
- Aztreonam: No alteration in pharmacokinetics when co-administered with linezolid 1
- Gentamicin: No pharmacokinetic changes with concurrent use 1
- Rifampin: The only antibiotic with documented interaction (21% decrease in linezolid Cmax and 32% decrease in AUC) 1
Linezolid does not induce or inhibit cytochrome P450 enzymes, and azithromycin is not metabolized through CYP450 pathways, eliminating concerns about metabolic drug interactions 1.
Critical Safety Consideration: Serotonin Syndrome Risk
The primary concern with this combination is the theoretical risk of serotonin syndrome, not pharmacokinetic interaction. Linezolid is a reversible, nonselective monoamine oxidase inhibitor 1. While azithromycin is not classically considered a serotonergic agent, macrolides have been rarely associated with serotonin syndrome when combined with other serotonergic drugs.
Monitoring recommendations:
- Watch for signs of serotonin syndrome: agitation, confusion, tachycardia, hypertension, hyperthermia, hyperreflexia, myoclonus
- This risk is generally low with azithromycin but increases if the patient is on other serotonergic medications (SSRIs, SNRIs, tramadol, meperidine)
- The combination is not contraindicated but requires clinical vigilance
Dosing Considerations for Your Patient
For your specific patient with GFR ≈ 66 mL/min receiving linezolid 600 mg every 12 hours:
The current linezolid dosing is appropriate. Based on recent pharmacokinetic studies:
- Patients with CrCL ≥60 mL/min should receive the standard 600 mg every 12 hours 2, 3
- Your patient's GFR of 66 mL/min falls into the normal dosing category
- No dose adjustment is needed for mild renal impairment 1, 4
Renal function-based linezolid dosing algorithm:
- CrCL ≥60 mL/min: 600 mg every 12 hours (your patient) 2
- CrCL 30-60 mL/min: Consider 600 mg every 24 hours or 450 mg every 12 hours 2, 3
- CrCL <30 mL/min: 450 mg every 24 hours or 300 mg every 12 hours 2, 3
Clinical Efficacy for Skin Infections
Both agents are appropriate for skin infections:
- Linezolid: Strongly recommended for complicated skin and soft tissue infections at 600 mg IV/PO every 12 hours 5
- The combination may provide broader coverage if polymicrobial infection is suspected
- Linezolid provides excellent tissue penetration with a saliva-to-plasma ratio of 1.2:1 1
Common Pitfalls to Avoid
Do not assume dose adjustment is needed for mild renal impairment (GFR >60 mL/min) - standard dosing applies 1, 2
Monitor for thrombocytopenia with linezolid, especially if treatment extends beyond 10-14 days - risk increases with trough concentrations >7.8-8 mg/L 2, 6
Avoid overlooking other serotonergic medications the patient may be taking - the combination of linezolid with multiple serotonergic agents significantly increases risk 1
Do not use this combination for pneumonia - linezolid alone is preferred for MRSA pneumonia, and azithromycin would not add benefit for typical linezolid-susceptible organisms 5
Bottom Line
The combination is pharmacokinetically safe and can be used together. The clinical question is whether both antibiotics are necessary for the specific infection. For a skin infection with positive culture, verify that the organism(s) require coverage by both agents. If linezolid alone covers the pathogen (as it does for MRSA, streptococci, and enterococci), adding azithromycin may be unnecessary unless atypical organisms or specific polymicrobial coverage is needed 7, 5.